Pancreatic Cancer

FDA Approves Somatuline Depot (Lanreotide) for Certain Neuroendocrine Tumors

The US Food and Drug Administration (FDA) has approved Somatuline Depot (lanreotide) to treat advanced gastrointestinal neuroendocrine tumors (also known as GI carcinoids) and advanced pancreatic neuroendocrine tumors.

Abraxane plus Gemzar Combination Improves Pancreatic Cancer Survival

Researchers in Arizona and their colleagues have found that adding Abraxane (nab-paclitaxel) to a standard chemotherapy treatment helped people with advanced pancreatic cancer live longer.

Healthy Diet Linked to Lower Risk of Pancreatic Cancer

People who most closely follow healthy eating guidelines may have a lower risk of pancreatic cancer , according to a new study. Read about it here.

Society-Funded Researchers Take Aim at Pancreatic Cancer

Pancreatic cancer is a seemingly unbreachable tumor, earning it a decades-long ranking as one of the most difficult cancers to treat.

Annual Report: More Than a Million Cancer Deaths Avoided in 2 Decades

Newly published statistics from the American Cancer Society show that cancer death rates in the U.S. continue to decrease.

Researchers Make Discoveries in Fight against Pancreatic Cancer

New discoveries are giving researchers hope about the future of detection and treatment of pancreatic cancer, one of the most difficult cancers to find early and treat effectively.

Heavy Drinking Linked to Pancreatic Cancer

Drinking 3 or more drinks per day may raise your risk of dying from pancreatic cancer, new research by the American Cancer Society shows.

Genetics, Signaling Paths Next Frontiers in Pancreatic Cancer Treatment

New treatment theories could offer new hope against pancreatic cancer,which has traditionally been difficult to treat.

Eating Charred, Well-done Meat May Increase Pancreatic Cancer Risk

Eating charred, well-done meat on a regular basis may increase your risk of pancreatic cancer by up to 60%, according to findings from a University of Minnesota study presented this week at the annual American Association of Cancer Research (AACR) meeting in Denver, Colorado.